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In Vivo Effects of a Thymosin a1-Containing Colostral Whey Product on
N eutrophils and Lymphocytes from Lactating Cows Without and With
Experimentally Induced Staphylococcus aureus Mastitis
Abstract
Two separate experiments evaluated ID-1 (a commercial bovine whey product containing 5200 pg of
thymosin α1/ml) as an immunotherapeutic agent in lactating cows. In the first experiment, cows without
mastitis were evaluated for blood leukogram, milk production, total and differential milk cell counts,
lymphocyte (Lc) blastogenesis, and neutrophil (PMN) functions (random and directed migration under
agarose, chemiluminescence, ingestion of bacteria, iodination, cytochrome C reduction, antibody-
independent neutrophil-mediated cytotoxicity, and antibody-dependent cell-mediated cytotoxicity) before
and after ID-1 therapy. ID-1 treatment resulted in a significant treatment group by time period interaction for
the relative proportion of mononuclear cells (MNC) in milk (P<0.009) and for PMN random migration
(P<0.01). Based on these interactions, ID-1 treatment appeared to slightly increase the proportion of small
MNC in milk and to increase random migration from pretreatment levels by 73% more than increases
observed in controls. No significant effect of ID-1 treatment on milk production, total milk somatic cell
counts, Lc blastogenesis, or other PMN functions was observed. In cows with experimental Staphylococcus
aureus intramammary infections, ID-1 treatment resulted in a significant decline in blood leukocyte count
(P<0.001) and blood PMN count (P<0.02), and maintained PMN random migration (P<0.01) while
controls declined and abrogated a depression in the ability of Lc to respond to mitogens (P<0.05) that
developed in controls as a result of S. aureus mastitis. Injection of ID-1 into cows had no adverse effect on their
overall health or level of milk production, but did cause subtle and potentially favorable changes in several in
vitro immune parameters. In spite of these subtle changes which might indicate increased resistance to
mastitis, cows actually developed a more severe S. aureus intramammary infection based on a 9% increase in
log10 bacterial shedding in milk.
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Kehrli, M.E., Jr., Nonnecke, B.J., Wood, R.L. and Roth, J.A., 1989. In vivo effects of a thymosin 
a,-containing colostral whey product on neutrophils and lymphocytes from lactating cows with-
out and with experimentally induced Staphylococcus aureus mastitis. Vet. Immunol. Immu-
nopathol., 20: 149-163. 
Two separate experiments evaluated ID-1 (a commercial bovine whey product containing 5200 
pg ofthymosin a 1/ml) as an immunotherapeutic agent in lactating cows. In the first experiment, 
cows without mastitis were evaluated for blood leukogram, milk production, total and differential 
milk cell counts, lymphocyte (Lc) blastogenesis, and neutrophil (PMN) functions (random and 
directed migration under agarose, chemiluminescence, ingestion of bacteria, iodination, cyto-
chrome C reduction, antibody-independent neutrophil-mediated cytotoxicity, and antibody-de-
pendent cell-mediated cytotoxicity) before and after ID-1 therapy. ID-1 treatment resulted in a 
significant treatment group by time period interaction for the relative proportion of mononuclear 
cells (MNC) in milk (P < 0.009) and for PMN random migration (P < 0.01). Based on these 
interactions, ID-1 treatment appeared to slightly increase the proportion of small MNC in milk 
and to increase random migration from pretreatment levels by 73% more than increases observed 
in controls. No significant effect of ID-1 treatment on milk production, total milk somatic cell 
counts, Lc blastogenesis, or other PMN functions was observed. 
In cows with experimental Staphylococcus aureus intramammary infections, ID-1 treatment 
resulted in a significant decline in blood leukocyte count (P < 0.001) and blood PMN count 
(P<0.02), and maintained PMN random migration (P<0.01) while controls declined and ab-
rogated a depression in the ability of Lc to respond to mitogens (P < 0.05) that developed in 
controls as a result of S. aureus mastitis. Injection of ID-1 into cows had no adverse effect on their 
overall health or level of milk production, but did cause subtle and potentially favorable changes 
in several in vitro immune parameters. In spite of these subtle changes which might indicate 
0165-2427/89/$03.50 © 1989 Elsevier Science Publishers B.V. 
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increased resistance to mastitis, cows actually developed a more severe S. aureus intramammary 
infection based on a 9% increase in log10 bacterial shedding in milk. 
INTRODUCTION 
Mastitis is the most costly disease affecting the dairy industry (Bramley and 
Dodd, 1984). The only proven mastitis control methods are germicidal teat 
dips and dry cow antibiotic therapy (Bramley and Dodd, 1984). Although pre-
vention is the key to mastitis control, elimination of existing intramammary 
infections (IMI) by spontaneous cure, treatment, or culling is very important. 
Treatment of mastitis in lactating cows is fraught with problems: ( 1) anti-
biotic residues in milk, ( 2) reduced efficacy of antibiotic treatment during lac-
tation, and ( 3) mastitis induced when aseptic technique is not used to admin-
ister antibiotics into the mammary gland. Ideally, the best approach to 
elimination of IMI would be to increase spontaneous cure rates by safely en-
hancing immune function during periods of peak susceptibility to mastitis. 
Peak IMI rates occur during the first and last two weeks of a 60-day, nonlac-
tating period (Smith et al., 1985). In addition, clinical mastitis has its highest 
incidence during early lactation (Malinowski et al., 1983; Syvajarvi et al., 1986). 
Thymic hormones have been reported to have restorative effects on immune 
cell function and to prevent microbial infections in humans and other species 
(Doria and Frasca, 1984; Ishitsuka et al., 1984; Salvin and Neta, 1984). Thy-
mosin a 1, a peptide produced by thymic epithelial cells, is reported to induce 
maturation ofT-helper lymphocytes and enhance neutrophil ( PMN) function 
in mice (Birr, 1984; Bistoni et al., 1985 ). A product (ID-1) (lmmuno-Dynam-
ics, Inc., Perry, lA) derived from bovine colostrum has been developed which 
has been claimed to reduce the cell count of milk from glands with subclinical 
IMI and early stages of clinical mastitis. Preliminary data indicated the pres-
ence of thymosin a 1 in ID-1 (unpublished results, R. Cockrum, Immuno-Dy-
namics, Inc.). Enhancement oflymphocyte (Lc) and PMN function by thy-
mosin a 1 may explain the purported efficacy of ID-1 in early or subclinical 
cases of mastitis. 
The purpose of these experiments was to determine the influence of ID-1 
administration on peripheral blood Lc and PMN function, bacterial shedding 
and somatic cell counts in milk from mastitis-free, lactating Holstein cows, 
and cows with experimental Staphylococcus aureus mastitis. 
MATERIALS AND METHODS 
Preparation of ID-1 from colostrum 
First milking colostrum was obtained from normal, healthy, adult cows and 
frozen at -10°C until processed. Thawed colostrum was strained through a 
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coarse filter, pooled, and heated to 27°C. Rennin and water (up to 20% final 
volume) were added to remove the casein by enzymatic coagulation. Whey was 
decanted and passed through a standard dairy high-volume clarifier to remove 
milk fat. Whey was then passed through a series of filters (two 0.45-J..lm filters, 
one 0.22-J..lm filter), and adjusted to a final pH of 5.4 to 5.6. Protein content 
was adjusted to 4% ( w / v) by dilution with physiologic saline solution. Phenol 
was used as a preservative at a final concentration of 0.4%. 
Analysis of thymosin a 1 content 
Thymosin a 1 content of milk, serum, and ID-1 was determined by radioim-
munoassay as previously validated for bovine thymosin a 1 in bovine tissues 
(assays performed by Dr. Paul H. Naylor, Dept. Biochemistry, George Wash-
ington University Medical Center, Washington, DC, according to procedure of 
McClure et al., 1982). Milk and serum samples from six Holstein cows were 
collected from the first, sixth, and twelfth milkings after calving. A prepartum 
serum sample was also collected. Thymosin a 1 content of the ID-1 (Lot# 384) 
used in this report was also determined. 
Animals and experimental design 
In experiment 1, twelve mid-lactation Holstein cows were randomly as-
signed into two groups. One group ( ID-1) received 40 ml of ID-1 injected sub-
cutaneously daily for 3 consecutive days (total dose of 0.6 j..lg thymosin a 1 per 
cow); the control group received 3 similar injections of pyrogen-free saline. 
Peripheral blood Lc and PMN functions were evaluated according to the fol-
lowing schedule: Period 1 =Monday, Wednesday, and Friday (MWF) [prior 
to ID-1 or placebo injections ( 3 consecutive 10 a.m. injections were given be-
ginning after samples were collected on Friday of Period 1 ) ] , Period 2 =Monday 
through Friday (MTWThF) (5 consecutive days starting 24 h after the final 
injection), and Period 3 =Monday, Wednesday, and Friday (8, 10, and 12 days 
after the final injection). 
In the week prior to experiment 2, all twelve cows were experimentally in-
fected in one quarter with ~50 colony-forming units of S. aureus and divided 
into two treatment groups with an equal number of cows ( 3) with or without 
previous exposure to ID-1 in each group. One group received ID-1, and the 
second served as the control. Identical treatment and sampling regimens were 
used in the first and second experiments. 
Hematological studies 
Total leukocyte count in blood was determined by electronic counting of 
blood collected by jugular venipuncture into tubes containing EDTA. Films of 
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blood cells were prepared by cytocentrifugation and stained with a combina-
tion Giemsa/Wright stain. Approximately 200 cells were differentiated as 
PMN, eosinophils (PME), or mononuclear cells (MNC). Lymphocytes and 
monocytes cannot be differentiated in bovine blood by this method, so they 
were counted together and termed MNC (Hammer and Weber, 1974). 
Milk sample evaluation 
Bacteriological examination of milk samples ( ~ 1-2 ml) was done daily from 
each mammary quarter before the a.m. milking. One-tenth ml of each quarter 
milk sample was plated onto tryptic soy agar with 5% sheep blood (Micro Bio 
Logics, St. Cloud, MN) and examined for bacterial growth after 24 and 48 h 
incubation at 37 o C. In the second experiment, milk from known infected mam-
mary quarters was briefly sonicated ( ~ 10 s) to break up clusters of staphylo-
cocci and to disrupt phagocytes which might contain viable bacteria (Hurley 
et al., 1985). Serial decimal dilutions of sonicated milk samples were made in 
0.015 M phosphate-buffered saline solution ( PBSS; pH 7.2), and 0.1 ml of each 
dilution was plated on duplicate blood agar plates and incubated for 18 h at 
37 o C. Bacterial colony numbers were expressed as log10 bacteria/ml of milk. 
Total numbers of milk leukocytes in midstream milk were estimated by the 
direct microscopic method (National Mastitis Council, 1968). Differential cell 
counts were determined by microscopic examination of cytocentrifuge slide 
preparations of milk as described above. Daily milk production was recorded 
throughout the experiments. 
Leukocyte preparation 
Neutrophils and MNC were separated from peripheral blood samples col-
lected into acid citrate dextrose as described (Kehrli et al., 1988a,b). The iso-
lated PMN pellets, which were typically>95% granulocytes (PMN + PME), 
were suspended in PBSS at a concentration of 5.0 X 107 /ml for functional anal-
ysis. The MNC harvested from density gradient centrifugation (Histopaque 
1083, Sigma) were washed twice in PBSS at 400 Xg for 10 min and then re-
suspended to a final concentration of 2 X 106 /ml in RPMI 1640 medium con-
taining 25 mM HEPES buffer and 2 mM L-glutamine. 
Neutrophil function assays 
Procedures for evaluating ingestion of 1251 -labeled S. aureus (Roth and Kae-
berle, 1981a), iodination (Roth and Kaeberle, 1981a), cytochrome C reduction 
(Canning et al., 1986), antibody-dependent cell-mediated cytotoxicity (ADCC) 
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(Roth and Kaeberle, 1981b), antibody-independent neutrophil-mediated cy-
totoxicity (AINC) (Roth and Kaeberle, 1981b), native (nonluminol-depen-
dent) chemiluminescence (Kehrli et al., 1988a), directed migration (Lukacs 
et al., 1985), and random migration under agarose by PMN (Nelson et al., 
1975) were done as described with minor modifications (Kehrli et al., 1988a). 
Neutrophil adherence was evaluated in the second experiment using [51Cr]-
labeled PMN on extracellular matrix-coated, flat-bottomed microtiter plates 
(Accurate Chemical and Scientific Corp., Westbury, NY). Isolated PMN (1 
ml) were incubated for 1 hat 39°C with 7.4 MBq of sodium chromate [51Cr] 
(Amersham) in 1 ml Medium 199 (M199) in a humidified atmosphere con-
taining 5% C02 • After two washings with 10 ml of PBSS, PMN were resus-
pended to 4 ml with M199 with 25 mM HEPES and 2 mM L-glutamine. Wells 
of microtiter plates were filled with 100 ,ul of M199 and prewarmed to 39°C 
before 100 ,ul of labeled PMN (1.25X106 ) were added. Cells were allowed to 
adhere for various time periods (0, 15, 30, 45, 60, and 90 min) before non-
adherent cells were washed away by three gentle irrigations/aspirations of the 
well with PBSS (39°C). Fifty microliters of Triton X100 (1% v/v) were added 
to each well to lyse and release the radiolabel in the remaining adherent PMN. 
Radioactivity released into the supernatant was then adsorbed by a microtiter 
supernatant collection system (SCS, Skatron). For analysis, the percent of 
total [ 51 Cr] -labeled PMN added per well that was adherent was plotted against 
time, and area under the curve was determined. 
Lymphocyte blastogenesis 
Lymphocyte blastogenesis was performed as previously described (Kehrli et 
al., 1988b). Media for mitogenic stimulation contained one of the following 
amounts of mitogen: 25, 12.5 or 6.25 ,ug of phytohemagglutinin-P (PHAP) 
(Difco ), 15.6, 7.8, or 3.9 ,ug of concanavalin-A (ConA) (Sigma), or 20, 2, or 
0.2 ,ug of pokeweed mitogen (PWM) (Sigma) per ml of medium. All three 
concentrations of each mitogen were averaged for an overall mean which was 
used in statistical analysis. 
Statistical analysis 
Variables were analyzed by fitting the linear model: y = mean + group + 
cow(group) +period+ day (period) + group*period + group*day (period) 
+ period* cow (group) + error. In this model, groups were the placebo- and 
ID-1-treated cows, periods were three individual weeks of each experiment, 
days were MWF, MTWThF, and MWF in the three periods, and error repre-
sented residual animal variation after fitting the above model. The effect of 
ID-1 treatment is in the group by period ( G * P) interaction. Therefore, statis-
tical significance was judged by F-tests of the G*P interaction. This model 
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allows for significant pretreatment differences between groups that may arise 
by chance, and assumes this difference remains constant over time unless ID-
1 treatment imparts a significant effect on the variable analyzed. 
RESULTS 
Thymosin a 1 determinations 
Colostrum for the first milking after calving had more than twice as much 
thymosin a 1 (4100 pg/ml) as did simultaneously collected autologous sera 
( 1900 pg/ml, Fig. 1). By the twelfth milking after calving, the thymosin a 1 
content of milk had gradually declined to 2400 pg/ml, while serum content 
remained the same (2000 pg/ml). The lot ofiD-1 used in this report contained 
5200 pg of thymosin a 1/ml. 
Experiment 1 
All 12 cows remained free of detectable IMI during the 3 weeks of the first 
experiment. 
Administration of ID-1 to cows without mastitis had no significant G*P 
effects on blood leukogram values, milk production, somatic cell count, or milk 
PMN count (data not shown). There was, however, a significant G*P 
(P < 0.009) for the proportion of small MNC in the milk cell population (Fig. 
2). This seems due to a slight increase in the relative proportion of small MNC 
in the milk cell population during the experiment in the ID-1 group. This sig-
nificant G*P for the proportion of small MNC in milk may be solely due to 
the large initial difference between treatment groups that arose by chance. 
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Fig. 2. Effect of ID-1 on the mean ( ± SEM) proportion of small mononuclear cells (presumably 
lymphocytes) in the milk leukocyte population of two groups of six cows without mastitis. One 
group was given placebo saline injections and the other was given ID-1 injections on 3 consecutive 
days before the second period (week) of the experiment. 
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Fig. 3. Random (a) and directed migration (b) under agarose activity of blood neutrophils col-
lected from two groups of six cows without mastitis. One group was given placebo saline injections 
and the other was given ID-1 injections on 3 consecutive days before the 2nd period (week) of the 
experiment. Points represent group means ( ± SEM) for each period of the experiment. 
Neutrophil random migration was found to be significantly affected by ID-
1 treatment ( G * P; P < 0.001). Administration of ID-1 to healthy lactating 
dairy cows resulted in a significantly larger proportional increase in PMN ran-
dom migration during the first week after treatment than the increase of PMN 
random migration from placebo controls (Fig. 3a). All other PMN functions 
and Lc blastogenesis results demonstrated parallel values between the two 
groups for the duration of experiment 1 (data not shown). Therefore, ID-1 
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administration to cows without mastitis had no significant influence on PMN 
ingestion of bacteria, PMN oxidative metabolism (measured by chemilumi-
nescence, cytochrome C reduction and iodination), PMN ADCC, or Lc blas-
togenic responses to mitogens (ConA, PHA-P, and PWM). 
Experiment 2 
There were significant G * P interactions for the effect of ID-1 treatment on 
the total blood leukocyte count (P<O.OOl) and on the blood PMN count 
(P<0.02) in cows with S. aureus mastitis. ID-1 treatment appeared to cause 
a slight leukopenia from pretreatment values compared to control values (Fig. 
4a). The net change in blood neutrophil counts after ID-1 treatment was a 
slight decline, while the control values went up slightly (Fig. 4b). 
Administration of ID-1 to cows with S. aureus mastitis did not significantly 
affect milk production or milk leukocyte values based on the G * P interactions 
(Table 1 ) . Some interesting trends did appear, however. Milk somatic cell count 
( SCC) values for the ID-1-treated cows were initially lower than the placebo-
injected controls (Table 1). The geometric mean SCC of the control cows had 
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Fig. 4. Total blood leukocyte count (a) and blood neutrophil count (b) of two groups of six cows 
with mastitis. One group was given placebo saline injections and the other was given ID-1 injec-
tions on 3 consecutive days before the 2nd period (week) of the experiment. Bars represent group 
means for each period of the experiment, and lines represent the SE. 
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TABLE 1 
Results of various milk parameters measured before and after three daily injections of ID-1 or a 
placebo into two groups of six cows with experimentally induced mastitis 
Treatment group Treatment 
effect 
Controls ID-1 G*P 
Parameter Period" Mean±SEM (n) Mean±SEM (n) Pvalue 
Milk production (kg/d) 20.6± 0.9 (18) 18.7± 0.7 (18) 
2 21.0± 0.7 (30) 18.8± 0.6 (30) NSb 
3 21.3± 0.9 (18) 18.6± 0.7 (18) 
Milk somatic cell countc 1 166 ±23 (30) 110 ±10 (30) 
(X103/ml) 2 302 ±49 (42) 166 ±15 (42) NS 
3 347 ±48 (42) 224 ±21 (42) 
Milk neutrophil countc 1 55 ±13 (30) 39 ± 6.3 (30) 
(X 103 /ml) 2 160 ±37 (42) 78 ± 8.9 (42) NS 
3 150 ±32 (42) 100 ±12 (42) 
% Neutrophils in milk 1 45 ± 6 (30) 41 ± 4 (30) 
cell population 2 63 ± 4 (42) 52 ± 3 (42) NS 
3 53 ± 4 (42) 51 ± 4 (42) 
% Small mononuclear 1 55 ± 6 (30) 59 ± 4 (30) 
cells in the milk 2 36 ± 4 (42) 47 ± 3 (42) NS 
population 3 46 ± 4 (42) 49 ± 4 (42) 
Bacteria shed in milk 1 5.1± 0.36 (18) 4.5± 0.30 (18) 
(log1o cells/ml) 2 4.8± 0.22 (30) 5.0± 0.11 (30) 0.008 
3 5.1± 0.32 (18) 4.9± 0.11 (18) 
"Period 1=Mon., Wed. and Fri. before treatment; Period 2=Mon. through Fri. after the last 
treatment; Period 3 =Mon., Wed. and Fri. after period 2. 
hNS=not significant (P> 0.05 ). 
<Geometric mean cell counts and SEM. 
increased 182% by the week after placebo injections as the S. aureus infections 
progressed. This increase represented a 31% larger proportional increase in 
the SCC than what was observed in the ID-1-treated group. This difference 
was not significant, however, as judged by the G*P. The relative proportion of 
PMN in the SCC and absolute number of PMN/ml of milk increased to a 
larger value in the control cows than in the ID-1 group (Table 1 ) . This was not 
significant, however. The proportion of small MNC in the milk cell population 
appeared to decline to a lesser degree in the ID-1-treated cows. Although this 
was not significant, it does agree with the results of our first experiment where 
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a slightly higher value was found for the proportion of small MNC in the milk 
cell population of ID-1-treated cows without IMI. 
Every quarter with an experimentally-induced IMI remained infected, based 
on daily culture results. The range of bacterial shedding values (bacteria/ml 
milk) was consistent for a given cow. The log10 bacteria/ml range for all quar-
ters of all cows was Oto 7. There was a significant G*P (P<0.008) for bacterial 
shedding into milk from infected quarters (Table 1). During the initial period 
after ID-1 treatment, there was a 9% log10 increase in bacterial shedding from 
the udder into the milk of cows receiving ID-1, while the controls experienced 
a 7% log10 drop in shedding of S. aureus. 
In experiment 2, a significant G * P was observed for the effect of ID-1 treat-
ment on PMN random migration (P < 0.01). ID-1 given to lactating dairy cows 
with mastitis the week after treatment resulted in higher PMN random migra-
tion values than control values (Fig. 5 ). No other effects ofiD-1 treatment on 
PMN function were detected (data not shown). 
ID-1 treatment had a significant G*P (P<0.05) effect on Lc blastogenesis 
stimulated by ConA and PHAP (Fig. 6). The effect of ID-1 treatment was to 
abrogate a depression in the ability of Lc to respond to mitogens that developed 
in the controls as S. aureus mastitis progressed (Fig. 6). This effect is less 
convincing for ConA due to the large pretreatment value difference between 
the two groups (Fig. 6b). 
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Fig. 6. Uptake of [3H]-thymidine by phytohemagglutinin- (a) and concanavalin A- (b) stimu-
lated cultures ofblood mononuclear cells collected from two groups of six cows with experimentally 
induced Staphylococcus aureus mastitis. One group was given placebo saline injections and the 
other was given ID -1 injections on 3 consecutive days before the 2nd period (week) of the exper-
iment. Points represent group means ( ± SEM) for each period of the experiment. 
DISCUSSION 
Thymosin a 1 was found to be present in bovine colostrum at levels more 
than twice as high as levels found in autologous sera. In addition, the thymosin 
a 1 content of the commercial whey product used in this study was slightly more 
than for colostrum. Bovine thymosin a 1 is an acidic peptide (M.W. 3108) with 
a pi of 4.2 (Goldstein et al., 1977). In humans, the concentration of thymosin 
a 1 in blood is highest in utero and decreases sharply after birth (McClure et 
al., 1982). Maternal blood levels ofthymosin a 1 also appear to be above normal 
during gestation in humans (McClure et al., 1982). High fetal blood levels of 
thymosin a 1 may contribute to these elevated maternal serum levels. The im-
portance of thymosin a 1 in bovine colostrum to the suckling calf is not known. 
The acidic nature ofbovine lacteal secretions (pH 6.6-7.2) compared to blood 
(pH 7.35-7.5) (Duncan and Prasse, 1977) may result in ion-trapping ofthy-
mosin a 1 in colostrum. An exhaustive compositional analysis of ID-1 has not 
been done to identify all of its biologically active components. Thymosin a 1 is 
just one of many possible, biologically active molecules in colostrum other than 
antibodies. 
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Biologic activity was detected for ID-1 in cows with S. aureus mastitis; how-
ever, the biologic significance of the observed changes on the outcome of mas-
titis is not known. ID-1 therapy did not significantly reduce the somatic cell 
count in milk from S. aureus-infected glands and was not effective as a sole 
therapeutic agent for experimentally induced S. aureus mastitis. 
Administration of ID-1 to apparently healthy cows resulted in a significant 
increase in PMN random migration. This effect can be interpreted as a loss of 
PMN stickiness and may reduce PMN egress from the blood stream into tis-
sues (Clark et al., 1979; Harmsen and Turney, 1985). In normal healthy ani-
mals, it is not known if this change may affect susceptibility to infectious dis-
ease such as mastitis. There were no other significant effects of ID-1 on 
peripheral blood PMN or Lc function detected in healthy cows. Most immu-
notherapeutic agents are intended to restore a faltering immune system. The 
primary objective of this form of therapy is to optimize host cellular immune 
responses. The lack of significant effects on immune cell function in healthy 
animals does not rule out the possibility of an immunotherapeutic agent en-
hancing immune function in an animal with comprised immune function. 
Cows in the ID-1 treatment group demonstrated a slight increase in the pro-
portion of small MNC in the milk cell population (Fig. 2). Lymphocytes pro-
duce lymphokines which can enhance phagocyte (PMN and macrophage) 
function in the bovine (Lukacs et al., 1985; Steinbeck et al., 1986). Whether 
this slight increase has any functional significance in the mammary gland re-
mains to be determined. 
ID-1 administration to cows infected with S. aureus in one or more quarters 
maintained PMN random migration, while the control's values declined (Fig. 
5). This is closely related to the observed increase in PMN random migration 
in cows without mastitis (Fig. 3). This activity is similar to the effect of glu-
cocorticoids in cattle (an increase in PMN random migration) (Roth et al., 
1982). However, the typical neutrophilia and depressed PMN iodination and 
Lc blastogenesis in cattle responding to glucocorticoids was not observed. We 
also observed a trend in the milk somatic cell count that might indicate fewer 
total leukocytes entering the mammary glands of the ID-1-treated infected 
cows as compared to the infected control cows (Table 1). The PMN adherence 
assay used in the second experiment did not indicate any loss of PMN adher-
ence. Our adherence assay performed on extracellular matrix-coated plates 
had a higher percentage of adherent PMN ( 32-40% adhering) than a previous 
assay using plain polystyrene plates (24% adhering) (Lukacs et al., 1985 ). 
As shown in Fig. 6, in infected control cows there was suppression of Lc 
blastogenesis which is in agreement with a pre'vious report on cows with chronic 
S. aureus mastitis (Nonnecke and Harp, 1985 ). Impairment in bovine periph-
eral blood Lc function has also been associated with other types of mastitis 
(Kashiwazaki, 1984). Suppression of Lc blastogenesis was not as marked in 
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the ID-1-treated cows (P < 0.05), indicating a potential immunotherapeutic 
effect of ID-1 on Lc (Fig. 6). This effect for ConA may be in part due to initial 
chance differences between the two groups of cows. However, the effect of ID-
1 on PHAP-induced Lc blastogenesis supports the idea of a significant, short-
term enhancement of Lc function. The role of milk Lc is not clearly defined, 
but it is plausible that they may affect PMN function for elaboration of lym-
phokines (Harmsen and Turney, 1985; Lukacs et al., 1985). 
Increased bacterial shedding from the udders of cows treated with ID-1 co-
incided with the time when Lc blastogenesis was sustained by ID-1 therapy. 
The biological significance of this increase in bacterial shedding is unknown. 
One can infer from this finding that ID-1 treatment actually worsened the IMI. 
This interpretation is a paradox to the more favorable effects on Lc blastoge-
nesis. Our bacterial shedding values include bacteria free in the milk and re-
maining viable bacteria released by sonic disruption of phagocytes in milk. 
Increased bacterial shedding could represent higher bacterial numbers in milk 
because of fewer phagocytes going into the gland to control bacteria, or more 
bacteria being phagocytosed and perhaps cleared from the udder by milk PMN 
and macrophages. The mild sonication of milk samples prior to bacterial enu-
meration was a very effective technique which yielded uniform and reproduc-
ible results from individual cows over the duration of the experiment. Nine of 
the 13 quarters evaluated for 19 consecutive days never deviated more than 
one log10 value from the mean shedding values. In addition, only one of 24 7 
total quarter samples cultured came up with noS. aureus isolation. We believe 
sonication of milk samples is a valuable technique to improve the sensitivity 
of bacterial culturing. Milk somatic cell counts were lower than we had antic-
ipated for cows with S aureus mastitis (e.g.> 600 000 cells/ml), which may 
have reduced our ability to detect any major effect ID-1 might have on cows 
with higher somatic cell counts. 
Immunotherapeutic agents often have subtle effects which sustain immune 
cell functions that may be faltering; effects of ID-1 on Lc and PMN function 
fit this description although all observed changes were small. A close relation-
ship between altered immunity and disease occurrence exists for mastitis and 
other diseases of cattle (Jain et al., 1968; Guidry et al., 1976; Newbould, 1976; 
Schalm et al., 1976; Hill et al., 1979; Hoerlein, 1980; Hill, 1981; Lofstedt et al., 
1983; Gunnink, 1984; Kashiwazaki, 1984; Kehrli et al., 1988a,b). Enhance-
ment or restoration of the immune system with immunotherapeutic agents 
could increase resistance to mastitis. It is possible that we did not adequately 
immunosuppress the cows in our experiments and therefore failed to detect 
more restorative effects of ID-1 on the bovine immune system. Periparturient 
cows (Kashiwazaki, 1984; Kehrli et al., 1988a, b) are more immunosuppressed 
than the cows with S. aureus mastitis in this report and might offer the oppor-
tunity to see greater effects of potential immunomodulator treatment. 
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